Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Konjugate des Maytansinoids DM1, über einen nicht spaltbaren Linker verknüpft mit Antikörper Trastuzumab, und deren Verwendung in der Behandlung von Tumoren.
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2004793896
EP Publication Number
1689846
E-Number
602948
Language
EN
PCT Number
US04030917
Publication Date
16.08.2006 A
27.03.2013 B1
Registration Date
27.03.2013
AT Publication Date
15.04.2013
Application Date
12.10.2004
Registration Number
-
Priorities
10.10.2003
US
509901 P
08.10.2004
US
960602
IPC
A61K 47/48 20060101AFI20100625BHEP
Maximum Duration of Protection
12.10.2024
Owner
ImmunoGen, Inc.830 Winter Street Waltham, MA 02451US